Bridging the Gap Between Participants and Clinical Trials


Find Clinical Trials

Generic filters
Search for
Clinical Trials

Get involved in local research! aims to connect individuals with relevant clinical trials.

Clinical trials are scientific studies usually testing new treatments, and are available for either healthy volunteers or individuals with specific illnesses. In the long run, your contribution gives hope for safe and effective treatments.


Get notified of future clinical trials

You can receive email notifications about new clinical trials as they are posted. Join our community to be informed of the studies that are relevant to you!

Frequently Asked Questions

Latest Clinical Trials

Painful Open Wound or Ulcer

Pendlebury Research is conducting a clinical study of an investigational wound pain treatment. You may be eligible if you are aged 18 or over, with at least one painful wound or ulcer that has been open for at least 14 days. All study medication and study care is provided at no cost. You will need…

Read More

Herbal supplements for Normalizing Elevated (pre-diabetic) Blood Glucose and improving Insulin Sensitivity

This is a 12 week study to test two herbal supplements (Trigonella foenum-graecum Seed Extract and Coccinia Grandis Extract)for Normalizing Elevated (pre-diabetic) Blood Glucose and improving Insulin Sensitivity. It is being conducted in Brisbane in QLD. Participants will be asked to come to the clinic 4 times over 3 months and have your blood glucose and insulin levels tested…

Read More

MYNAP Study – Melatonin trial for young people with ADHD and sleep disorder

Attention Deficit Hyperactivity Disorder (ADHD) is a common behavioural condition that affects thousands of children and families in Australia. ADHD is a complex disorder involving difficulties with hyperactivity, concentration and attention. Children with ADHD often have difficulty sleeping, especially problems trying to settle down in the evening. This can be complicated by the medications used to…

Read More

Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old

A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients With Type 2 Diabetes Mellitus Who Are Between 10 and Below 18 Years of Age.

Read More